Blog
RSS FeedPosted by Michael Wonder on 17 Dec 2018
Decision to fund a new hepatitis C treatment (Maviret) and to widen access to adalimumab (Humira) for psoriasis
17 December 2018 - PHARMAC is pleased to announce a decision to fund a new treatment for chronic hepatitis C ...
Posted by Michael Wonder on 16 Dec 2018
Transparency Commission publishes its opinion for Kymriah
14 December 2018 - Opinion published following an examination of written submissions on 12 December 2018. ...
Posted by Michael Wonder on 16 Dec 2018
Proposal to harmonise, streamline and transition the Cancer Drug Implementation Advisory Committee to CADTH
14 December 2018 - Providing customised implementation support to decision-makers at all levels of the health system is a key ...
Posted by Michael Wonder on 16 Dec 2018
2019 oncology drugs in pipeline — survey
14 December 2018 - pCODR is again undertaking its periodic survey to facilitate consistent and systematic data collection from participating ...
Posted by Michael Wonder on 15 Dec 2018
Recommendations made by the PBAC - November 2018
14 December 2018 - The outcomes from the November 2018 PBAC meeting are now available but not in full. ...
Posted by Michael Wonder on 15 Dec 2018
Price disclosure 2019 April cycle outcomes summary
14 December 2018 - The summary of price disclosure price reductions for the 2019 April Cycle has now been published. ...
Posted by Michael Wonder on 14 Dec 2018
Decision in relation to infliximab, tocilizumab and rituximab
14 December 2018 - PHARMAC is pleased to announce a decision on how three hospital medicines (infliximab, tocilizumab and rituximab) ...
Posted by Michael Wonder on 13 Dec 2018
Outcomes from the November 2018 PBAC meeting
14 December 2018 - Published on the PBS website later today; full analysis in Monday's issue of MAESTrO Daily. ...
Posted by Michael Wonder on 13 Dec 2018
Brexit contributes to surge in generic drug prices
13 December 2018 - Calls for government to protect pharmacies. ...
Posted by Michael Wonder on 13 Dec 2018
Frustrated at cancer treatment inequity
13 December 2018 - As appointed ambassador for the Lung Foundation NZ, I feel very frustrated the Government will not ...
Posted by Michael Wonder on 12 Dec 2018
PBS - 2018 in review
13 December 2018 - The high number of new listings on the PBS in 2018 serves to debunk Bill Shorten's ...
Posted by Michael Wonder on 12 Dec 2018
NICE says no to rival Alnylam and Akcea amyloidosis drugs – but deal could be done
12 December 2018 - Room for manoeuvre after initial rejection. ...
Posted by Michael Wonder on 12 Dec 2018
New NICE standards to improve digital health tech uptake
12 December 2018 - NICE has published new standards setting out the requirements needed to develop digital health technologies for ...
Posted by Michael Wonder on 12 Dec 2018
Morrison government unveils $1.25 billion health funding fix
12 December 2018 - Prime Minister Scott Morrison will unveil a $1.25 billion offer to fund cancer treatment, drug and ...
Posted by Michael Wonder on 12 Dec 2018
Health organisations join calls for a review into government drug buying agency
12 December 2018 - Pressure is mounting on the government to announce a review into its drug buying agency with ...